Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nordson MARCH is a global leader in plasma processing technology, providing advanced plasma treatment systems for the semiconductor, printed circuit board, and medical device industries. The company's systems are used to improve surface adhesion, cleaning, and biocompatibility of medical components such as catheters, stents, and ophthalmic lenses. With a focus on surface engineering, Nordson MARCH offers a range of batch and in-line plasma systems designed to enhance manufacturing yields and product reliability. The company operates as a division of Nordson Corporation and serves the life sciences sector by providing critical surface modification solutions for implantable devices and diagnostic equipment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on March Plasma Systems.